Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$2.5M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 5 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 11 most recent Form 4 transactions.
| Open the original filing on SEC.gov |
| Feb 18 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 817 | $473.68 | $387K | -3.8% | Open the original filing on SEC.gov |
| Feb 17 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 2,031 | $489.46 | $994.1K | -8.6% | Open the original filing on SEC.gov |
| Feb 17 | VRTX | Vertex Pharmaceuticals… | FTAX◷ | 1,530 | $483.75 | $740.1K | -6.1% | Open the original filing on SEC.gov |
| Feb 17 | VRTX | Vertex Pharmaceuticals… | AGRANT◷ | 4,962 | — | — | +24.6% | Open the original filing on SEC.gov |
| Feb 13 | VRTX | Vertex Pharmaceuticals… | FTAX | 1,903 | $487.76 | $928.2K | -8.6% | Open the original filing on SEC.gov |
| Feb 11 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 1,751 | $460.43 | $806.2K | -7.4% | Open the original filing on SEC.gov |
| Feb 10 | VRTX | Vertex Pharmaceuticals… | FTAX◷ | 872 | $468.41 | $408.5K | -3.5% | Open the original filing on SEC.gov |
| Jan 22 | VRTX | Vertex Pharmaceuticals… | AGRANT | 3,883 | — | — | +18.7% | Open the original filing on SEC.gov |
| Jan 22 | VRTX | Vertex Pharmaceuticals… | AGRANT | 3,934 | — | — | +23.3% | Open the original filing on SEC.gov |